The global Acute Respiratory Distress Syndrome Therapeutics market was valued at US$ 388.6 million in 2022 and is projected to reach US$ 476.9 million by 2029, at a CAGR of 3.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Respiratory distress syndrome is caused by pulmonary surfactant deficiency in the lungs of neonates, most commonly in those born at < 37 weeks gestation. Risk increases with degree of prematurity. Symptoms and signs include grunting respirations, use of accessory muscles, and nasal flaring appearing soon after birth. Diagnosis is clinical; prenatal risk can be assessed with tests of fetal lung maturity. Treatment is surfactant therapy and supportive care. Treatment for RDS usually begins as soon as a newborn is born, sometimes in the delivery room. Treatments for RDS include surfactant replacement therapy, breathing support from a ventilator or nasal continuous positive airway pressure (NCPAP) machine, or other supportive treatments.
This report aims to provide a comprehensive presentation of the global market for Acute Respiratory Distress Syndrome Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acute Respiratory Distress Syndrome Therapeutics. This report contains market size and forecasts of Acute Respiratory Distress Syndrome Therapeutics in global, including the following market information:
Global Acute Respiratory Distress Syndrome Therapeutics Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
North America is the largest consumption place, with a consumption market share nearly 33% . Following North America, China is the second largest consumption place with the consumption market share of 26%.The key manufacturers are Chiesi Farmaceutici, CR-Double Crane, ONY Biotech, AbbVie, Yuhan Corporation, JW Pharmaceuticals, Noargen etc. Top 3 companies occupied about 85% market share.
We surveyed the Acute Respiratory Distress Syndrome Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Acute Respiratory Distress Syndrome Therapeutics Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Acute Respiratory Distress Syndrome Therapeutics Market Segment Percentages, by Type, 2022 (%)
- Methylprednisolone
- Hydrocortisone
- Calf Pulmonary Surfactant for Injection
- Others
Global Acute Respiratory Distress Syndrome Therapeutics Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Acute Respiratory Distress Syndrome Therapeutics Market Segment Percentages, by Application, 2022 (%)
Global Acute Respiratory Distress Syndrome Therapeutics Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Acute Respiratory Distress Syndrome Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Acute Respiratory Distress Syndrome Therapeutics revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Acute Respiratory Distress Syndrome Therapeutics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Therabron Therapeutics, Inc.
- Serendex Pharmaceuticals A/S
- Silence Therapeutics Plc
- Histocell S.L.
- Altor BioScience Corporation
- Athersys, Inc.
- Faron Pharmaceuticals Oy
- FirstString Research, Inc.
- GlaxoSmithKline Plc
- Phylogica Limited
Outline of Major Chapters:
Chapter 1: Introduces the definition of Acute Respiratory Distress Syndrome Therapeutics, market overview.
Chapter 2: Global Acute Respiratory Distress Syndrome Therapeutics market size in revenue.
Chapter 3: Detailed analysis of Acute Respiratory Distress Syndrome Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Acute Respiratory Distress Syndrome Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Acute Respiratory Distress Syndrome Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Acute Respiratory Distress Syndrome Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Acute Respiratory Distress Syndrome Therapeutics Overall Market Size
2.1 Global Acute Respiratory Distress Syndrome Therapeutics Market Size: 2022 VS 2030
2.2 Global Acute Respiratory Distress Syndrome Therapeutics Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Acute Respiratory Distress Syndrome Therapeutics Players in Global Market
3.2 Top Global Acute Respiratory Distress Syndrome Therapeutics Companies Ranked by Revenue
3.3 Global Acute Respiratory Distress Syndrome Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Acute Respiratory Distress Syndrome Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Acute Respiratory Distress Syndrome Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Acute Respiratory Distress Syndrome Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Acute Respiratory Distress Syndrome Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Acute Respiratory Distress Syndrome Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Acute Respiratory Distress Syndrome Therapeutics Market Size Markets, 2022 & 2030
4.1.2 Methylprednisolone
4.1.3 Hydrocortisone
4.1.4 Calf Pulmonary Surfactant for Injection
4.1.5 Others
4.2 By Type - Global Acute Respiratory Distress Syndrome Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Acute Respiratory Distress Syndrome Therapeutics Revenue, 2018-2023
4.2.2 By Type - Global Acute Respiratory Distress Syndrome Therapeutics Revenue, 2024-2030
4.2.3 By Type - Global Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Acute Respiratory Distress Syndrome Therapeutics Market Size, 2022 & 2030
5.1.2 In-Patient
5.1.3 Out-Patient
5.2 By Application - Global Acute Respiratory Distress Syndrome Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Acute Respiratory Distress Syndrome Therapeutics Revenue, 2018-2023
5.2.2 By Application - Global Acute Respiratory Distress Syndrome Therapeutics Revenue, 2024-2030
5.2.3 By Application - Global Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Acute Respiratory Distress Syndrome Therapeutics Market Size, 2022 & 2030
6.2 By Region - Global Acute Respiratory Distress Syndrome Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Acute Respiratory Distress Syndrome Therapeutics Revenue, 2018-2023
6.2.2 By Region - Global Acute Respiratory Distress Syndrome Therapeutics Revenue, 2024-2030
6.2.3 By Region - Global Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Acute Respiratory Distress Syndrome Therapeutics Revenue, 2018-2030
6.3.2 US Acute Respiratory Distress Syndrome Therapeutics Market Size, 2018-2030
6.3.3 Canada Acute Respiratory Distress Syndrome Therapeutics Market Size, 2018-2030
6.3.4 Mexico Acute Respiratory Distress Syndrome Therapeutics Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Acute Respiratory Distress Syndrome Therapeutics Revenue, 2018-2030
6.4.2 Germany Acute Respiratory Distress Syndrome Therapeutics Market Size, 2018-2030
6.4.3 France Acute Respiratory Distress Syndrome Therapeutics Market Size, 2018-2030
6.4.4 U.K. Acute Respiratory Distress Syndrome Therapeutics Market Size, 2018-2030
6.4.5 Italy Acute Respiratory Distress Syndrome Therapeutics Market Size, 2018-2030
6.4.6 Russia Acute Respiratory Distress Syndrome Therapeutics Market Size, 2018-2030
6.4.7 Nordic Countries Acute Respiratory Distress Syndrome Therapeutics Market Size, 2018-2030
6.4.8 Benelux Acute Respiratory Distress Syndrome Therapeutics Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Acute Respiratory Distress Syndrome Therapeutics Revenue, 2018-2030
6.5.2 China Acute Respiratory Distress Syndrome Therapeutics Market Size, 2018-2030
6.5.3 Japan Acute Respiratory Distress Syndrome Therapeutics Market Size, 2018-2030
6.5.4 South Korea Acute Respiratory Distress Syndrome Therapeutics Market Size, 2018-2030
6.5.5 Southeast Asia Acute Respiratory Distress Syndrome Therapeutics Market Size, 2018-2030
6.5.6 India Acute Respiratory Distress Syndrome Therapeutics Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Acute Respiratory Distress Syndrome Therapeutics Revenue, 2018-2030
6.6.2 Brazil Acute Respiratory Distress Syndrome Therapeutics Market Size, 2018-2030
6.6.3 Argentina Acute Respiratory Distress Syndrome Therapeutics Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Acute Respiratory Distress Syndrome Therapeutics Revenue, 2018-2030
6.7.2 Turkey Acute Respiratory Distress Syndrome Therapeutics Market Size, 2018-2030
6.7.3 Israel Acute Respiratory Distress Syndrome Therapeutics Market Size, 2018-2030
6.7.4 Saudi Arabia Acute Respiratory Distress Syndrome Therapeutics Market Size, 2018-2030
6.7.5 UAE Acute Respiratory Distress Syndrome Therapeutics Market Size, 2018-2030
7 Acute Respiratory Distress Syndrome Therapeutics Companies Profiles
7.1 Therabron Therapeutics, Inc.
7.1.1 Therabron Therapeutics, Inc. Company Summary
7.1.2 Therabron Therapeutics, Inc. Business Overview
7.1.3 Therabron Therapeutics, Inc. Acute Respiratory Distress Syndrome Therapeutics Major Product Offerings
7.1.4 Therabron Therapeutics, Inc. Acute Respiratory Distress Syndrome Therapeutics Revenue in Global Market (2018-2023)
7.1.5 Therabron Therapeutics, Inc. Key News & Latest Developments
7.2 Serendex Pharmaceuticals A/S
7.2.1 Serendex Pharmaceuticals A/S Company Summary
7.2.2 Serendex Pharmaceuticals A/S Business Overview
7.2.3 Serendex Pharmaceuticals A/S Acute Respiratory Distress Syndrome Therapeutics Major Product Offerings
7.2.4 Serendex Pharmaceuticals A/S Acute Respiratory Distress Syndrome Therapeutics Revenue in Global Market (2018-2023)
7.2.5 Serendex Pharmaceuticals A/S Key News & Latest Developments
7.3 Silence Therapeutics Plc
7.3.1 Silence Therapeutics Plc Company Summary
7.3.2 Silence Therapeutics Plc Business Overview
7.3.3 Silence Therapeutics Plc Acute Respiratory Distress Syndrome Therapeutics Major Product Offerings
7.3.4 Silence Therapeutics Plc Acute Respiratory Distress Syndrome Therapeutics Revenue in Global Market (2018-2023)
7.3.5 Silence Therapeutics Plc Key News & Latest Developments
7.4 Histocell S.L.
7.4.1 Histocell S.L. Company Summary
7.4.2 Histocell S.L. Business Overview
7.4.3 Histocell S.L. Acute Respiratory Distress Syndrome Therapeutics Major Product Offerings
7.4.4 Histocell S.L. Acute Respiratory Distress Syndrome Therapeutics Revenue in Global Market (2018-2023)
7.4.5 Histocell S.L. Key News & Latest Developments
7.5 Altor BioScience Corporation
7.5.1 Altor BioScience Corporation Company Summary
7.5.2 Altor BioScience Corporation Business Overview
7.5.3 Altor BioScience Corporation Acute Respiratory Distress Syndrome Therapeutics Major Product Offerings
7.5.4 Altor BioScience Corporation Acute Respiratory Distress Syndrome Therapeutics Revenue in Global Market (2018-2023)
7.5.5 Altor BioScience Corporation Key News & Latest Developments
7.6 Athersys, Inc.
7.6.1 Athersys, Inc. Company Summary
7.6.2 Athersys, Inc. Business Overview
7.6.3 Athersys, Inc. Acute Respiratory Distress Syndrome Therapeutics Major Product Offerings
7.6.4 Athersys, Inc. Acute Respiratory Distress Syndrome Therapeutics Revenue in Global Market (2018-2023)
7.6.5 Athersys, Inc. Key News & Latest Developments
7.7 Faron Pharmaceuticals Oy
7.7.1 Faron Pharmaceuticals Oy Company Summary
7.7.2 Faron Pharmaceuticals Oy Business Overview
7.7.3 Faron Pharmaceuticals Oy Acute Respiratory Distress Syndrome Therapeutics Major Product Offerings
7.7.4 Faron Pharmaceuticals Oy Acute Respiratory Distress Syndrome Therapeutics Revenue in Global Market (2018-2023)
7.7.5 Faron Pharmaceuticals Oy Key News & Latest Developments
7.8 FirstString Research, Inc.
7.8.1 FirstString Research, Inc. Company Summary
7.8.2 FirstString Research, Inc. Business Overview
7.8.3 FirstString Research, Inc. Acute Respiratory Distress Syndrome Therapeutics Major Product Offerings
7.8.4 FirstString Research, Inc. Acute Respiratory Distress Syndrome Therapeutics Revenue in Global Market (2018-2023)
7.8.5 FirstString Research, Inc. Key News & Latest Developments
7.9 GlaxoSmithKline Plc
7.9.1 GlaxoSmithKline Plc Company Summary
7.9.2 GlaxoSmithKline Plc Business Overview
7.9.3 GlaxoSmithKline Plc Acute Respiratory Distress Syndrome Therapeutics Major Product Offerings
7.9.4 GlaxoSmithKline Plc Acute Respiratory Distress Syndrome Therapeutics Revenue in Global Market (2018-2023)
7.9.5 GlaxoSmithKline Plc Key News & Latest Developments
7.10 Phylogica Limited
7.10.1 Phylogica Limited Company Summary
7.10.2 Phylogica Limited Business Overview
7.10.3 Phylogica Limited Acute Respiratory Distress Syndrome Therapeutics Major Product Offerings
7.10.4 Phylogica Limited Acute Respiratory Distress Syndrome Therapeutics Revenue in Global Market (2018-2023)
7.10.5 Phylogica Limited Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Acute Respiratory Distress Syndrome Therapeutics Market Opportunities & Trends in Global Market
Table 2. Acute Respiratory Distress Syndrome Therapeutics Market Drivers in Global Market
Table 3. Acute Respiratory Distress Syndrome Therapeutics Market Restraints in Global Market
Table 4. Key Players of Acute Respiratory Distress Syndrome Therapeutics in Global Market
Table 5. Top Acute Respiratory Distress Syndrome Therapeutics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Acute Respiratory Distress Syndrome Therapeutics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Acute Respiratory Distress Syndrome Therapeutics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Acute Respiratory Distress Syndrome Therapeutics Product Type
Table 9. List of Global Tier 1 Acute Respiratory Distress Syndrome Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Acute Respiratory Distress Syndrome Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Acute Respiratory Distress Syndrome Therapeutics Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Acute Respiratory Distress Syndrome Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Acute Respiratory Distress Syndrome Therapeutics Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Acute Respiratory Distress Syndrome Therapeutics Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Acute Respiratory Distress Syndrome Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Acute Respiratory Distress Syndrome Therapeutics Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Acute Respiratory Distress Syndrome Therapeutics Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Acute Respiratory Distress Syndrome Therapeutics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Acute Respiratory Distress Syndrome Therapeutics Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Acute Respiratory Distress Syndrome Therapeutics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Acute Respiratory Distress Syndrome Therapeutics Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Acute Respiratory Distress Syndrome Therapeutics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Acute Respiratory Distress Syndrome Therapeutics Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Acute Respiratory Distress Syndrome Therapeutics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Acute Respiratory Distress Syndrome Therapeutics Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Acute Respiratory Distress Syndrome Therapeutics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Acute Respiratory Distress Syndrome Therapeutics Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Acute Respiratory Distress Syndrome Therapeutics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Acute Respiratory Distress Syndrome Therapeutics Revenue, (US$, Mn), 2024-2030
Table 30. Therabron Therapeutics, Inc. Company Summary
Table 31. Therabron Therapeutics, Inc. Acute Respiratory Distress Syndrome Therapeutics Product Offerings
Table 32. Therabron Therapeutics, Inc. Acute Respiratory Distress Syndrome Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 33. Therabron Therapeutics, Inc. Key News & Latest Developments
Table 34. Serendex Pharmaceuticals A/S Company Summary
Table 35. Serendex Pharmaceuticals A/S Acute Respiratory Distress Syndrome Therapeutics Product Offerings
Table 36. Serendex Pharmaceuticals A/S Acute Respiratory Distress Syndrome Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 37. Serendex Pharmaceuticals A/S Key News & Latest Developments
Table 38. Silence Therapeutics Plc Company Summary
Table 39. Silence Therapeutics Plc Acute Respiratory Distress Syndrome Therapeutics Product Offerings
Table 40. Silence Therapeutics Plc Acute Respiratory Distress Syndrome Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 41. Silence Therapeutics Plc Key News & Latest Developments
Table 42. Histocell S.L. Company Summary
Table 43. Histocell S.L. Acute Respiratory Distress Syndrome Therapeutics Product Offerings
Table 44. Histocell S.L. Acute Respiratory Distress Syndrome Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 45. Histocell S.L. Key News & Latest Developments
Table 46. Altor BioScience Corporation Company Summary
Table 47. Altor BioScience Corporation Acute Respiratory Distress Syndrome Therapeutics Product Offerings
Table 48. Altor BioScience Corporation Acute Respiratory Distress Syndrome Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 49. Altor BioScience Corporation Key News & Latest Developments
Table 50. Athersys, Inc. Company Summary
Table 51. Athersys, Inc. Acute Respiratory Distress Syndrome Therapeutics Product Offerings
Table 52. Athersys, Inc. Acute Respiratory Distress Syndrome Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 53. Athersys, Inc. Key News & Latest Developments
Table 54. Faron Pharmaceuticals Oy Company Summary
Table 55. Faron Pharmaceuticals Oy Acute Respiratory Distress Syndrome Therapeutics Product Offerings
Table 56. Faron Pharmaceuticals Oy Acute Respiratory Distress Syndrome Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 57. Faron Pharmaceuticals Oy Key News & Latest Developments
Table 58. FirstString Research, Inc. Company Summary
Table 59. FirstString Research, Inc. Acute Respiratory Distress Syndrome Therapeutics Product Offerings
Table 60. FirstString Research, Inc. Acute Respiratory Distress Syndrome Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 61. FirstString Research, Inc. Key News & Latest Developments
Table 62. GlaxoSmithKline Plc Company Summary
Table 63. GlaxoSmithKline Plc Acute Respiratory Distress Syndrome Therapeutics Product Offerings
Table 64. GlaxoSmithKline Plc Acute Respiratory Distress Syndrome Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 65. GlaxoSmithKline Plc Key News & Latest Developments
Table 66. Phylogica Limited Company Summary
Table 67. Phylogica Limited Acute Respiratory Distress Syndrome Therapeutics Product Offerings
Table 68. Phylogica Limited Acute Respiratory Distress Syndrome Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 69. Phylogica Limited Key News & Latest Developments
List of Figures
Figure 1. Acute Respiratory Distress Syndrome Therapeutics Segment by Type in 2022
Figure 2. Acute Respiratory Distress Syndrome Therapeutics Segment by Application in 2022
Figure 3. Global Acute Respiratory Distress Syndrome Therapeutics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Acute Respiratory Distress Syndrome Therapeutics Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Acute Respiratory Distress Syndrome Therapeutics Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Acute Respiratory Distress Syndrome Therapeutics Revenue in 2022
Figure 8. By Type - Global Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share, 2018-2030
Figure 9. By Application - Global Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share, 2018-2030
Figure 10. By Type - Global Acute Respiratory Distress Syndrome Therapeutics Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share, 2018-2030
Figure 12. By Application - Global Acute Respiratory Distress Syndrome Therapeutics Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share, 2018-2030
Figure 14. By Region - Global Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share, 2018-2030
Figure 15. By Country - North America Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share, 2018-2030
Figure 16. US Acute Respiratory Distress Syndrome Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Acute Respiratory Distress Syndrome Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Acute Respiratory Distress Syndrome Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share, 2018-2030
Figure 20. Germany Acute Respiratory Distress Syndrome Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 21. France Acute Respiratory Distress Syndrome Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Acute Respiratory Distress Syndrome Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Acute Respiratory Distress Syndrome Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Acute Respiratory Distress Syndrome Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Acute Respiratory Distress Syndrome Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Acute Respiratory Distress Syndrome Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share, 2018-2030
Figure 28. China Acute Respiratory Distress Syndrome Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Acute Respiratory Distress Syndrome Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Acute Respiratory Distress Syndrome Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Acute Respiratory Distress Syndrome Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 32. India Acute Respiratory Distress Syndrome Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share, 2018-2030
Figure 34. Brazil Acute Respiratory Distress Syndrome Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Acute Respiratory Distress Syndrome Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share, 2018-2030
Figure 37. Turkey Acute Respiratory Distress Syndrome Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Acute Respiratory Distress Syndrome Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Acute Respiratory Distress Syndrome Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Acute Respiratory Distress Syndrome Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 41. Therabron Therapeutics, Inc. Acute Respiratory Distress Syndrome Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Serendex Pharmaceuticals A/S Acute Respiratory Distress Syndrome Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Silence Therapeutics Plc Acute Respiratory Distress Syndrome Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Histocell S.L. Acute Respiratory Distress Syndrome Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Altor BioScience Corporation Acute Respiratory Distress Syndrome Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Athersys, Inc. Acute Respiratory Distress Syndrome Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Faron Pharmaceuticals Oy Acute Respiratory Distress Syndrome Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. FirstString Research, Inc. Acute Respiratory Distress Syndrome Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. GlaxoSmithKline Plc Acute Respiratory Distress Syndrome Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Phylogica Limited Acute Respiratory Distress Syndrome Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
